These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32367637)

  • 61. Oral Ulcers as an Initial Presentation of Juvenile Pemphigus: A Case Report.
    Chen IH; Mu SC; Tsai D; Chou YY; Wang LF; Wang LJ
    Pediatr Neonatol; 2016 Aug; 57(4):338-42. PubMed ID: 24295781
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment of pemphigus.
    Piamphongsant T; Ophaswongse S
    Int J Dermatol; 1991 Feb; 30(2):139-46. PubMed ID: 2001906
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical efficacy of rituximab in the treatment of pemphigus: A retrospective study.
    Sharma VK; Bhari N; Gupta S; Sahni K; Khanna N; Ramam M; Sethuraman G
    Indian J Dermatol Venereol Leprol; 2016; 82(4):389-94. PubMed ID: 27279296
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ultra-low dose rituximab for refractory pemghigus vulgaris: a pilot study.
    Russo I; Miotto S; Saponeri A; Alaibac M
    Expert Opin Biol Ther; 2020 Jun; 20(6):673-678. PubMed ID: 32027810
    [No Abstract]   [Full Text] [Related]  

  • 65. Pemphigus vegetans with coexistent herpes simplex infection and deep venous thrombosis of the lower extremities.
    Marchalik R; Reserva J; Plummer MA; Braniecki M
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26178000
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pemphigus vegetans presenting as acrodermatitis continua suppurativa.
    Török L; Husz S; Ocsai H; Krischner A; Kiss M
    Eur J Dermatol; 2003; 13(6):579-81. PubMed ID: 14721779
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy of perilesional and intralesional triamcinolone acetonide injections in pemphigus vulgaris lesions of the scalp: an effective therapeutic option.
    Sar-Pomian M; Czuwara J; Grygorowicz T; Mirowska-Guzel D; Cudnoch-Jedrzejewska A; Rudnicka L; Olszewska M
    Clin Exp Dermatol; 2018 Mar; 43(2):168-170. PubMed ID: 28994133
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment of pemphigus vegetans to rituximab refractory to conventional therapy.
    Ruiz-Villaverde R; Galán-Gutierrez M; Sanchez-Cano D
    Acta Dermatovenerol Croat; 2014; 22(3):221-3. PubMed ID: 25230067
    [No Abstract]   [Full Text] [Related]  

  • 69. Pemphigus vegetans of the tongue: a diagnostic and therapeutic challenge.
    Apalla Z; Sotiriou E; Lazaridou E; Manousari A; Trigoni A; Papagarifallou I; Ioannides D
    Int J Dermatol; 2013 Mar; 52(3):350-1. PubMed ID: 23414160
    [No Abstract]   [Full Text] [Related]  

  • 70. A rare case of pemphigus vegetans mimicking malignancy on F-18 FDG PET/CT.
    D'souza MM; D'souza PV; Jaimini A; Sharma R; Tripathi M; Singh D; Mondal A
    Clin Nucl Med; 2011 Mar; 36(3):248-51. PubMed ID: 21285693
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pemphigus vulgaris-vegetans.
    Roenigk HH; Fowler-Bergfeld W
    Arch Dermatol; 1969 Jan; 99(1):123-4. PubMed ID: 5761795
    [No Abstract]   [Full Text] [Related]  

  • 72. Pemphigus in North-Western Yemen: A therapeutic study of 75 cases.
    Khatri ML
    Indian J Dermatol Venereol Leprol; 2016; 82(3):359. PubMed ID: 27088959
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gefitinib induced Pemphigus Vulgaris with PRIDE complex.
    Kumar Chaudhary R; Bhandari R; Doshi B; Karoli SS; Spoorthi Marripalli S; Ganachari MS
    J Oncol Pharm Pract; 2022 Sep; 28(6):1465-1473. PubMed ID: 35102778
    [No Abstract]   [Full Text] [Related]  

  • 74. Pemphigus vulgaris--still a difficult disease to treat.
    Menezes N; Leite I; Tente D; Couceiro A; Baptista A; Varela P
    Int J Dermatol; 2010 Feb; 49(2):230-2. PubMed ID: 20465654
    [No Abstract]   [Full Text] [Related]  

  • 75. [Rituximab induced remission of pemphigus vulgaris: 2 cases].
    Borel C; Launay F; Garrouste C; Astudillo L; Bazex J; Arlet P; Paul C; Viraben R; Sailler L
    Rev Med Interne; 2007 Apr; 28(4):266-8. PubMed ID: 17188405
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Extensive keloid formation after pemphigus vulgaris.
    Sako EY; Workwick S
    Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632939
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rituximab therapy in severe juvenile pemphigus vulgaris.
    Mamelak AJ; Eid MP; Cohen BA; Anhalt GJ
    Cutis; 2007 Oct; 80(4):335-40. PubMed ID: 18038698
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Oral and cutaneous pemphigus vulgaris: an atypical clinical presentation.
    Goldberg IM; Brooks JK; Ghita I; Sultan AS; MacKelfresh JB
    Gen Dent; 2022; 70(6):22-26. PubMed ID: 36288071
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nasal, pharyngeal, and laryngeal pemphigus vulgaris successfully treated with rituximab.
    Sami N
    Ear Nose Throat J; 2017; 96(4-5):E35-E38. PubMed ID: 28489243
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pilot study of 19 patients with severe pemphigus: prophylactic treatment with rituximab does not appear to be beneficial.
    Gregoriou S; Giatrakou S; Theodoropoulos K; Katoulis A; Loumou P; Toumbis-Ioannou E; Papadavid E; Avgerinou G; Stavrianeas N; Rigopoulos D
    Dermatology; 2014; 228(2):158-65. PubMed ID: 24557145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.